Physician profile
Daniel Brooks Levin
NPI 1952796997
$43,922.39
in general payments reported to CMS, 2019-2025
16 companies · $3,736 in 2025
The $3,736 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.17 · 2020: $97.05 · 2021: $4,419 · 2022: $21K · 2023: $6,176 · 2024: $8,680 · 2025: $3,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,707 · Food and Beverage: $8,317 · Grant: $1,500 · Education: $68.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,706.84 |
| Food and Beverage | $8,316.75 |
| Grant | $1,500.00 |
| Education | $68.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $39,002.77 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Affera Mapping System |
| Biotronik INC. | $1,518.97 | 2021-2023 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,300.58 | 2021-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Cardiva Medical, INC. | $693.57 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm, Optowire |
| Biosense Webster, INC. | $354.04 | 2024-2025 | Carto 3 |
| Abbott Laboratories | $322.16 | 2023-2025 | Ensite Precision, Proclaim, Tacticath Ablation Catheter, Sensor Enabled |
| Novartis Pharmaceuticals Corporation | $131.14 | 2023-2024 | |
| Amgen INC. | $130.90 | 2023-2025 | Repatha |
| Abiomed | $123.73 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $91.50 | 2020 | |
| Medtronic Vascular, INC. | $88.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.39 | 2024-2025 | Lifevest |
| Baxter Healthcare | $50.98 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $21.09 | 2024 | Wainua |
| Pfizer INC. | $15.85 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $5.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.